| セッション情報 | パネルディスカッション8(肝臓学会・消化器病学会合同)東アジアにおける肝疾患の問題点と治療の特色 |
|---|---|
| タイトル | 肝PD8-5指：Characteristics of liver diseases and treatment in Mongolia |
| 演者 | O. Baatarkhuu（Department of Infectious Diseases, Health Sciences University） |
| 共同演者 | D. Y. Kim（Department of Internal Medicine, Yonsei University College of Medicine） |
| 抄録 | Mongolia has a unique feature regarding liver diseases in that prevalence of chronic hepatitis C (HCV) and co-infection of hepatitis B and D is very high. Within the apparently healthy individuals, the prevalence of anti-HCV, and HCV RNA were found to be 15.6% and 11.0%, respectively, and most HCV infection is caused by genotype 1b. The most significant risk factors of HCV spread has been found to be re-use of needles and syringes, prior history of dental or surgical procedures, and blood transfusion. Accordingly, hepatocellular carcinoma (HCC) is the most common malignancy in Mongolia due to the high prevalence of HCV infection and high proportion of patients who do not receive optimal therapy of pegylated interferon and ribavirin. Prevalence of HBV is appr. 10% among unvaccinated populations and caused by genotype D. Hepatitis D virus (HDV) can be acquired either by coinfection in which an individual is confronted with both HDV and HBV virues simultaneously, or by superinfection of individuals who are already chronically infected with HBV. There are insufficient data on HDV infection in Mongolia despite of high prevalence of this viral infection in this country. |
| 索引用語 | Liver disease, Hepatitis |